Brookstone Hires Head of Life Sciences Investments

Nov 11 2005 | 9:22pm ET

Scott Moonly has been appointed v.p. of life science investments for Brookstone Capital, which specializes in alternative investment opportunities.

Moonly, who joins the firm from L.E.K. Consulting, will be responsible for identifying life science investment opportunities and performing due diligence on both private and public companies. He holds a Ph.D. in biomedical engineering.

In addition to working at L.E.K. Consulting, Moonly has served as an investment analyst with the Merrill Lynch Healthcare Group where he provided financial and strategic analysis for biotechnology and medical device companies. Brookstone has offices in Costa Mesa, Calif. and Las Vegas.

< Previous Article Next Article >

More News

OpenFin Taps Ex-Goldman Sachs Tech Exec Walker For Board Role

In Depth

Q&A: Old Hill's Stone On Private Debt, P2P And Credit Bubbles

Jun 6 2017 | 7:52pm ET

While institutional capital continues to flow into the broader private debt sector...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

AIMA: How The U.K.'s SMCR Will Affect U.S. Firms

Jun 20 2017 | 6:29pm ET

U.S. investment managers need to think seriously about how tough new U.K. conduct...

Error

FINalternatives Trending

Platinum Partners Saga Reignites Concerns About Cayman 'Beach Boards'

Ex-Weiss, UBS Execs Prepping Launch of New Multi-Strategy Hedge Fund

Melkman's Light Sky Macro Said To Be Backed By Hedge Fund Giants

more >>

From the current issue of

Beyond the tear sheet: War stories from the front lines of hedge fund due diligence

Investing in private partnership structures such as hedge funds, private equity and private real estate can be a fruitful and exciting endeavor, especially when venturing into asset classes that lack competition and efficiency. An important qualification to remember when beginning due diligence on a partnership is that no investment is perfect. Each one has its own risks, however esoteric or idiosyncratic, and risks change over time, as do the operations and other intricacies of investment management.